Luxembourg: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthMonthsYears
23412131415-235-6912131415-16171860-64≥ 65
Coronavirus disease (COVID-19)1
COVID-192
rotavirus infection
ROTA
ROTA
diphtheria
D
D
D
D
D
d3
tetanus
TT
TT
TT
TT
TT
TT3
pertussis
acP
acP
acP
acP
acP
acP3
poliomyelitis
IPV
IPV
IPV
IPV
IPV
IPV3
Haemophilus influenzae type b infection
Hib
Hib
Hib
Hib
hepatitis B
HepB4
HepB
HepB
HepB
HepB5
pneumococcal disease
PCV
PCV
PCV
PCV
PPSV236
PCV13+PPSV236
meningococcal disease
MenB7
MenC
MenB7
MenC8
MenB7
measles
MEAS
MEAS
MEAS9
mumps
MUMPS
MUMPS
MUMPS9
rubella
RUBE
RUBE
RUBE9
varicella
VAR
VAR
human papillomavirus infection
HPV (F/M)10
HPV (F/M)11
influenza
IIV4

Version:


Footnotes:

  1. https://sante.public.lu/fr/actualites/2020/12/communique-strategie-vaccination/index.html
  2. https://sante.public.lu/fr/actualites/2020/12/communique-strategie-vaccination/index.html https://covid19.public.lu/dam-assets/covid-19/documents/strategie-vaccinale/CSMI-avis-priorisation-vaccin-COVID-19-phases-2-et-suivantes-20210127.pdf
  3. Subsequent Tdacp-IPV booster every 10 years
  4. Babies born to a mother infected with hepatitis B will be offered a first dose at birth
  5. if no history of vaccination
  6. It is recommended that populations at risk and elderly 65 years of age and over receive a dose of 13-valent pneumococcal conjugate vaccine (PCV13) followed, 8 weeks later, by a dose of 23-valent pneumococcal polysaccharide vaccine (PCV23). In the present state of knowledge, the CSMI recommends a PPV23 recall only in people at risk, who are recalled every 5 years. Children at risk of invasive pneumococcal infection are also affected by this recommendation: in the absence of previous vaccination with PCV13, catch-up is indicated. For mopre informeation: http://www.sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/index.html
  7. Two/three doses recommended in at-risk groups, depending on age. Further information available at: http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-avis-vaccination-meningocoque-groupe-b.pdf
  8. see http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-vaccination-meningocoque-c.pdf
  9. Given the resurgence of measles, all adults born after 1980 who have not received two doses of measles, mumps and rubella vaccines should recall the MMR vaccine
  10. 9-valent. Gender-neutral (boys and girls) vaccination offered. Two doses with 6 months interval
  11. Three doses


More information available at:
http://www.sante.public.lu/fr/prevention/vaccination/index.html


-------------------------------------------------------------------------------------------------------------------------

ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.

MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups

Date of last update: 16 Dec 2020

-------------------------------------------------------------------------------------------------------------------------